CHAULMOOGRA HYDNOCARPUS SPP

CHAULMOOGRA (Hydnocarpus spp.) X

The medicinally most important species in this taxonomically difficult genus are Hydnocarpus anthelminthicus Pierre ex Laness, H. kurzii (King.) Warb. (a.k.a. Taraktogenos kurzii), and H. pentandrus (Buch. Ham) Oken (formerly H. wightianus Bl.). Rightly or wrongly, PH2 and EFS took the generic approach so entries do not necessarily apply to a given species. HHB and WOI maintain them as distinct, but I have followed the expedient but sloppy generic approach. Without voucher specimens, none of us really know what was intended.

Activities (Chaulmoogra) :
- Anthelminthic (f; HHB); Antibacterial (f; KAP); Antiinflammatory (1; PH2); Antipyretic (1; EFS; PH2); Antiseptic (1; FNF; PH2); Antitumor (1; PH2); CNS-Depressant (f; MAD); CNS-Stimulant (f; MAD); Cyanogenic (f; PH2); Emetic (f; DEP); Laxative (1; DEP); Lipolytic (1; PH2); Parasiticide (f; EFS); Piscicide (f; HHB); Sedative (f; EFS; PH2).

Indications (Chaulmoogra) :
- Adenopathy (f; MAD); Arthrosis (f; MAD); Bacteria (f; KAP); Bruise (f; DEP); Cancer (1; JLH; PH2); Dermatosis (f; HHB; KAB; PH2); Diabetes (f; PH2); Eczema (f; PH2); Fever (1; EFS; PH2; WOI); Furuncle (f; PH2); Gas (f; PH2); Gout (f; MAD); Infection (1; PH2); Inflammation (1; PH2); Insomnia (f; EFS; PH2); Itch (f; DEP; PH2); Leprosy (1; EFS; KAP; PH2); Leukoderma (f; PH2); Lupus (f; EFS); Obesity (1; PH2); Nervousness (f; EFS; PH2); Ophthalmia (f; KAB; PH2); Parasite (f; EFS); Phthisis (f; DEP); Psoriasis (f; PH2); Pulmonosis (f; DEP); Rheumatism (f; DEP; MAD); Scabies (f; PH2); Scald (f; KAB); Sciatica (f; DEP); Scrofula (f; EFS); Sore (f; DEP; KAB); Sprain (f; DEP); Syphilis (f; DEP; MAD); Tuberculosis (1; HHB; KAP); Tumor (1; PH2); Wound (f; DEP; KAB).

Dosages (Chaulmoogra) :
- 0.3 ml oil 3 ×/day, to a max dose of 4 ml/day (HHB); 1 - 4 ml oil (KAP); 1 - 3 g powdered seed (KAP).

Contraindications, Interactions, and Side Effects (Chaulmoogra) :
- Not covered (AHP). Overdoses may induce CNS ups and downs, cramping, dyspnea, headache, myalgia, nausea, nephrosis, respiratory problems, and visual disorders (MAD).